Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Combining light therapy with CPAP for treating depression

Official title: Effects of Light Therapy on Compliance With Continuous Positive Airway Pressure in a Population of Depressed Patients Newly Fitted With Devices for Obstructive Sleep Apnea

Run by Hôpital le Vinatier · NCT06781593 · Data updated 2026-11-12

This study is testing if adding light therapy to CPAP treatment can help adults with depression and sleep apnea stick to their therapy better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment130 (estimated)
SponsorHôpital le Vinatier
Academic / other
Locations2 sites (Bron, France and 1 other locations)
StatusRecruiting
StartedJanuary 17, 2025
Main results expectedOctober 30, 2027
Study endsOctober 30, 2027
Registry record updatedApril 29, 2025
Trial IDNCT06781593 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults diagnosed with major depressive disorder and obstructive sleep apnea who require CPAP treatment.

Probably not a fit

Patients with unstable psychiatric conditions or contraindications to light therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of two weeks of light therapy combined with continuous positive airway pressure (CPAP) on improving compliance in patients suffering from major depressive disorder (MDD) and obstructive sleep apnea (OSA). The study aims to recruit 130 adults diagnosed with MDD and OSA, assessing whether the addition of light therapy can enhance adherence to CPAP treatment. The trial is designed as a double-blind, parallel-group controlled trial, focusing on the relationship between sleep disturbances and depressive symptoms. By addressing both conditions simultaneously, the study seeks to improve overall patient outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly improve CPAP compliance and alleviate depressive symptoms in patients with MDD and OSA.

How similar studies have gone: While the combination of light therapy and CPAP is a novel approach, existing studies have shown that treating sleep disturbances can improve depressive symptoms.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron
* Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15
* Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP.

Exclusion Criteria:

* Refusal to participate.
* Pregnant and breast-feeding women
* Under guardianship or curatorship.
* Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators.
* Other psychiatric, neurologic or somatic conditions
* Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less than 3 months).

patient wishing to choose a provider other than the protocol provider.

* Patient wishing to choose a device other than SEFAM's S-BOX or a mask other than the nasal mask at the time of introduction.
* Nasal obstruction.
* Refusal to use actimetry, refusal to use light therapy, refusal to use CPAP.

Where it's running

  • Centre Hospitalier le Vinatier
    Bron, France, France
    Recruiting
  • Centre Hospitalier le Vinatier
    Bron, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.